OS from randomization in patients with NPM1^mut, with or without co-occurring FLT3-ITD, at AML diagnosis. (A) NPM1^mut without co-occurring FLT3-ITD. (B) NPM1^mut with co-occurring FLT3-ITD. “Other” includes study patients without the specific genetic status at diagnosis.